Current status and prospect in the treatment of glioblastoma
10.3760/cma.j.issn.0529-5815.2020.01.015
- VernacularTitle: 脑胶质母细胞瘤的治疗现状与展望
- Author:
Haihui JIANG
1
;
Song LIN
Author Information
1. Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing Neurosurgical Institute, Beijing 100070, China
- Publication Type:Journal Article
- Keywords:
Glioblastoma;
Treatment outcome;
Precision medicine;
Treatment;
Prognosis
- From:
Chinese Journal of Surgery
2020;58(1):70-74
- CountryChina
- Language:Chinese
-
Abstract:
Glioblastoma (GBM) is the most common primary intracranial malignancy. The comprehensive treatment mode based on surgical resection has become the key to improve the prognosis of GBM and the quality of life of patients. This article reviews the progress of GBM in the fields of surgery, radiotherapy, chemotherapy, targeted therapy and immunotherapy during the past twenty years, mainly explores the similarities and differences between the treatment strategies of newly diagnosed and recurrent GBM and analyzes the difficulties in the current clinical practice of GBM.
